Tower Research Capital (TRC)’s Kazia Therapeutics KZIA Stock Holding History
Bought
Maintained
Sold
Other funds holding KZIA
DIG
Tower Research Capital (TRC)'s KZIA Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Kazia Therapeutics (KZIA) in Q3 2026: 934 shares worth $8.96K. The stake represents ﹤0.01% of the portfolio and ranks #4390 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in KZIA as recently as Q4 2016.
Tower Research Capital (TRC) first reported a position in KZIA in Q2 2013 and has held it in 7 quarters since. The position peaked at $42K in Q2 2015. 55 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.
- Tower Research Capital (TRC) held 934 shares of Kazia Therapeutics worth $8.96K as of Q3 2026.
- Kazia Therapeutics was a new Tower Research Capital (TRC) position in Q3 2026.
- Kazia Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4390 holding.
- Tower Research Capital (TRC) first reported a position in Kazia Therapeutics in Q2 2013 and has held it in 7 quarters since.
- Tower Research Capital (TRC)'s Kazia Therapeutics position peaked at $42K in Q2 2015.
- 55 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.